ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
2.
SolomonAJArrambideGBrownleeWJ, et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol2023; 22: 750–768.
3.
HewardKRoy-HewitsonCSolomonA. Multiple sclerosis presenting with paroxysmal symptoms. Patients at the limit of current diagnostic criteria. Mult Scler2024.
4.
OstermannPOWesterbergCE. Paroxysmal attacks in multiple sclerosis. Brain1975; 98: 189–202.
5.
TranchantCBhatiaKPMarsdenCD. Movement disorders in multiple sclerosis. Mov Disord1995; 10: 418–423.
6.
KempsterPARollinsonRD. The Lhermitte phenomenon: Variant forms and their significance. J Clin Neurosci2008; 15(4): 379–381.
7.
SavoldiFNasrZHuW, et al. McArdle sign: A specific sign of multiple sclerosis. Mayo Clin Proc2019; 94(8): 1427–1435.
8.
WijnandsJMAKingwellEZhuF, et al. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: A matched cohort study. Lancet Neurol2017; 16(6): 445–451.
9.
MakhaniNTremlettH. The multiple sclerosis prodrome. Nat Rev Neurol2021; 17: 515–521.
10.
MarrieRA. Mounting evidence for a multiple sclerosis prodrome. Nat Rev Neurol2019; 15(12): 689–690.
11.
OkudaDTMowryEMBeheshtianA, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology2009; 72: 800–805.
12.
Lebrun-FrenayCOkudaDTSivaA, et al. The radiologically isolated syndrome: Revised diagnostic criteria. Brain2023; 146: 3431–3443.
13.
OkudaDTKantarciOLebrun-FrénayC, et al. Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Ann Neurol2023; 93(3): 604–614.
14.
Lebrun-FrenayCSivaASormaniMP, et al. Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: The TERIS randomized clinical trial. JAMA Neurol2023; 80: 1080–1088.
